AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced it will create two new divisions by the end of this year as part of its ongoing growth strategy. Reflecting the expansion and growth opportunities of its vascular closure, cardiology, and electrophysiology product lines, the Company's Daig Division will become two new divisions: Cardiology and Atrial Fibrillation. Both new divisions will be headquartered at the current Daig Division location in Minnetonka, Minnesota.
The St. Jude Medical Cardiology Division will be led by Paul R. Buckman who is joining St. Jude Medical with more than 30 years experience in the medical technology industry including Chairman and CEO of ev3 LLC and President of the worldwide interventional cardiology and radiology businesses of Boston Scientific Corporation from 2000 to 2001. The Cardiology Division will focus on maximizing St. Jude Medical's technology, products and services for cardiovascular catheterizations. The division will build on the market leadership position of the Company's Angio-Seal(TM)…
Source: HighBeam Research, St. Jude Medical Creates New Business Units and Announces New...